$2.13
0.094.41%
At close: -
$2.13
0.000100.00%
After Hours: Mar 21, 7:53 PM EDT
Comments
Loading...
Akebia Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AKBA | Benzinga
Akebia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.080
Quarterly Revenue Estimate
$35.61M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$160.18M
Analyze the earnings history of Akebia Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics | -$0.09 | -$0.08 | — | — | $32.61M | $35.61M | — | — | 05/08/2025 | Get Alert |
| AKBA | Akebia Therapeutics | $0.00 | -$0.08 | -$0.10 | -25.00% | $56.20M | $37.36M | $46.50M | 24.46% | 03/13/2025 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.08 | -$0.06 | -$0.10 | -66.67% | $42.05M | $44.51M | $37.43M | -15.91% | 11/07/2024 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.06 | -$0.05 | -$0.04 | 20.00% | $56.38M | $49.45M | $43.65M | -11.73% | 08/08/2024 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.14 | -$0.08 | -$0.09 | -12.50% | $40.13M | $46.34M | $32.61M | -29.64% | 05/09/2024 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.04 | -$0.04 | $0.00 | 100.00% | $55.78M | $55.39M | $56.20M | 1.46% | 03/14/2024 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.28 | -$0.08 | -$0.08 | 0.00% | $48.96M | $48.18M | $42.05M | -12.73% | 11/08/2023 | Get Alert |
| AKBA | Akebia Therapeutics | $0.15 | -$0.02 | -$0.06 | -200.00% | $126.76M | $59.10M | $56.38M | -4.61% | 08/25/2023 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.35 | -$0.15 | -$0.14 | 6.67% | $61.70M | $46.68M | $40.13M | -14.04% | 05/08/2023 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.40 | -$0.19 | -$0.04 | 78.95% | $59.60M | $47.40M | $55.18M | 16.41% | 03/09/2023 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.34 | -$0.17 | -$0.28 | -64.71% | $48.76M | $48.88M | $48.96M | 0.17% | 11/03/2022 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.51 | -$0.31 | $0.23 | 174.19% | $52.91M | $49.73M | $126.76M | 154.89% | 08/04/2022 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.45 | -$0.29 | -$0.35 | -20.69% | $52.30M | — | $61.70M | — | 05/09/2022 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.60 | -$0.33 | -$0.40 | -21.21% | $56.70M | $50.80M | $59.60M | 17.33% | 03/01/2022 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.42 | -$0.32 | -$0.34 | -6.25% | $59.99M | $49.67M | $48.76M | -1.84% | 11/04/2021 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.44 | -$0.32 | -$0.51 | -59.38% | $90.14M | $52.88M | $52.91M | 0.06% | 08/05/2021 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.47 | -$0.36 | -$0.45 | -25.00% | $88.48M | $42.84M | $52.30M | 22.09% | 05/10/2021 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.79 | -$0.40 | -$0.60 | -50.00% | $69.56M | $51.16M | $56.70M | 10.83% | 02/25/2021 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.46 | -$0.17 | -$0.42 | -147.06% | $91.98M | $84.90M | $59.99M | -29.34% | 11/05/2020 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.25 | -$0.50 | -$0.44 | 12.00% | $100.80M | $74.18M | $90.14M | 21.52% | 08/10/2020 | Get Alert |
| AKBA | Akebia Therapeutics | -$0.44 | -$0.62 | -$0.47 | 24.19% | $72.67M | $77.48M | $88.48M | 14.19% | 05/05/2020 | Get Alert |
Akebia Therapeutics (AKBA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.10 | $-0.08 | -25.0 % |
| Q3 | 2024-11-07 | $-0.10 | $-0.06 | -66.7 % |
| Q2 | 2024-08-08 | $-0.04 | $-0.05 | 20.0 % |
| Q1 | 2024-05-09 | $-0.09 | $-0.08 | -12.5 % |
Akebia Therapeutics (AKBA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $46.50M | $37.36M | 24.5 % |
| Q3 | 2024-11-07 | $37.43M | $44.51M | -15.9 % |
| Q2 | 2024-08-08 | $43.65M | $49.45M | -11.7 % |
| Q1 | 2024-05-09 | $32.61M | $46.34M | -29.6 % |
FAQ
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
Akebia Therapeutics (AKBA) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Akebia Therapeutics (NASDAQ:AKBA)?
The Actual EPS was $-0.10, which missed the estimate of $-0.08.
What were Akebia Therapeutics’s (NASDAQ:AKBA) revenues?
The Actual Revenue was $46.5M, which beat the estimate of $37.4M.
Browse earnings estimates, EPS, and revenue on all stocks.